Highlights and Quick Summary
- Revenue Growth for the quarter ending September 30, 2023 was -0.69 (a -129.06% decrease compared to previous quarter)
- Year-over-year quarterly Revenue Growth decreased by -1048.69%
- Annual Revenue Growth for 2022 was 0.2 (a 50350.0% increase from previous year)
- Annual Revenue Growth for 2021 was 0.0 (a -99.97% decrease from previous year)
- Annual Revenue Growth for 2020 was 1.32 (a -332.06% decrease from previous year)
- Twelve month Revenue Growth ending September 30, 2023 was 0.23 (a -70.55% decrease compared to previous quarter)
- Twelve month trailing Revenue Growth increased by 13.73% year-over-year
Trailing Revenue Growth for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| 0.23 | 0.78 | 0.37 | 0.2 |
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Revenue Growth of Absci Corporation
Most recent Revenue Growthof ABSI including historical data for past 10 years.Interactive Chart of Revenue Growth of Absci Corporation
Absci Corporation Revenue Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -0.69 | 2.36 | 0.55 | – | – |
| 2022 | 0.07 | 0.54 | 0.38 | -0.23 | 0.2 |
| 2021 | -0.47 | 0.68 | 0.29 | 0.86 | 0.0 |
| 2020 | 0.88 | -0.4 | -0.23 | -0.46 | 1.32 |
| 2019 | – | – | – | – | -0.57 |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology